A new study published in the Journal of Neuroimmune Pharmacology has found that delta-9-tetrahydrocannabinol (THC) – one of the prime compounds in cannabis – can potentially stop organ transplant rejections from t aking place.

The study, which found that the higher the dose of THC, the higher the chance of protecting against rejection, also found synthetic cannabinoids to share a similar protective ability.

This data supports the potential of this class of compounds [cannabinoids] to be used as therapies to prolong graft survival in transplant patients, the study concludes.

According to researchers – although this study is one of the most detailed of its type – these findings aren’t particularly new; Cannabinoids were reported to have effects on immune responses as early as the 1970s, states the study.

The study was conducted by researchers at Temple University in Philadelphia.

– TheJointBlog